CFR Steps Back from India Buy

Nov 20, 2012

CFR Pharmaceuticals will withdraw its attempt to acquire 50% of India-based Stellence Pharmscience Private Limited, due to terms of...

To continue reading please take a free trial, subscribe or login below.

Already have an account?


Subscribe now for unlimited access to all current and archive news, data and market analysis. 


Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

Upcoming Events


Where will capital markets be busiest in 2017?